Medical News

RSS

AlloSource, Wright Medical Group enter supply and distribution agreement for FUSIONFLEX graft

Wright Medical Group, a global orthopaedic medical device company, today announced a supply and distribution agreement with AlloSource for FUSIONFLEX™ Bone Matrix, a unique bone repair scaffold for use in primary fusion procedures of the foot and ankle, as well as other orthopaedic bone grafting applications.

11 Jan 2011

Population of highly active neurons could provide insight into neocortex

Carnegie Mellon University researchers have found that within the brain's neocortex lies a subnetwork of highly active neurons that behave much like people in social networks.

11 Jan 2011

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

UCLA researchers have found that a protein that plays an important role in some antioxidant therapies may not be as effective due to additional mechanisms that cause it to promote atherosclerosis, or clogging of the arteries.

11 Jan 2011

PPD announces joint venture with TBL to develop novel biotherapeutics

PPD, today announced it has established a joint venture with Taijitu Biologics Limited in the area of the discovery of novel biotherapeutics. The joint venture, named BioDuro Biologics, expands PPD's capability to deliver unique, highly differentiated drug discovery services for biopharmaceutical companies across the globe.

10 Jan 2011

IGI Laboratories submits second abbreviated new drug application to FDA

IGI Laboratories, a New Jersey based formulation and manufacturing company, today announced that it has submitted its second abbreviated new drug application to the US FDA.

10 Jan 2011

Teleflex announces acquisition of VasoNova

Teleflex Incorporated, a leading global provider of medical technology products, today announced it has acquired privately-held VasoNova Inc. in a transaction valued at up to $55 million.

10 Jan 2011

Opsens files patent application for OptoWire diagnostic tool for measuring FFR

Opsens announces that it has recently filed a patent application for the OptoWire, a second diagnostic tool to assess coronary lesions by doing Fractional Flow Reserve.

10 Jan 2011

Ifa Systems acquires inoveon

ifa Systems AG, the global leader for IT solutions in ophthalmology based in Cologne, Germany, announced the acquisition of inoveon Corporation, proven experts in detection, staging, and monitoring of diabetic retinopathy and macular edema.

10 Jan 2011

Enobia Pharma completes ENB-0040 Phase II study in juveniles with hypophosphatasia

Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.

10 Jan 2011

Close pregnancies increase autism risk: Study

According to a new study published in the February issue of Paediatrics, children born within one year of an older sibling may be three times more likely to be diagnosed with autism.

10 Jan 2011

Games and entertainment for patients in hospitals

The British Medical Association (BMA) says these simple measures can beat boredom and keep patients happy and should be offered by hospitals. The BMA explains that the period of confinement can be a grim experience for some leading to depression. The latest BMA report looks at the emotional needs of patients.

10 Jan 2011

Women’s tears dampen men’s libido: Study

New research confirms an age old fear – men are truly turned off if the woman sheds tears. The researchers found that men who smelled the tears of weeping women produced less testosterone and found female faces less arousing.

10 Jan 2011

Floods may become a healthcare challenge, warns the AMA

The Australian Medical Association (AMA) has issued warnings to the Queensland health authorities to prepare for the rise of illnesses and injuries caused by the floods.

10 Jan 2011

Multiple sclerosis gene connection from women to offspring: Study

A new study has shown that women pass on the multiple sclerosis (MS) gene more commonly than men to their offspring. The team analyzed DNA of more than 7,000 people and found that women were also more likely to pass on the gene to female relatives. This may explain why women are up to three times more likely to get MS than men. The study was funded by the MS Society and led by George Ebers at Oxford University. It was published in the journal Neurology.

10 Jan 2011

VCU Massey Cancer Center introduces safer, more effective form of radiation therapy

Virginia Commonwealth University Massey Cancer Center has introduced a safer and more effective form of radiation therapy to treat cancer. The Center now offers volumetric modulated arc therapy (VMAT) delivery using the Philips Pinnacle3 SmartArc software to provide radiation treatment for multiple tumor sites, including prostate, head and neck, brain, breast and lung. VCU Massey is the first cancer center in the Richmond area to offer this cutting-edge radiation technique.

10 Jan 2011

United Medical Systems announces acquisition of Breast Surgical Services

United Medical Systems announces the acquisition of Breast Surgical Services, a Woodlands, Texas-based company for an undisclosed cash amount. The acquisition of Breast Surgical Services will expand UMS' stereotactic operations throughout Southern Texas.

10 Jan 2011

Access Intelligence announces acquisition of OR Manager

Access Intelligence LLC and its Dorland Health division announced today the acquisition of OR Manager, the premier media brand and annual educational conference and trade show for operating room executives, managers and hospital directors. This acquisition represents Access Intelligence's growing role in the healthcare management industry within four niche markets: medical coding, case management, patient advocacy and operating room management.

10 Jan 2011

World's first drug eluting bioresorbable vascular scaffold receives CE Mark approval

Abbott announced today that it has received CE Mark approval for the world's first drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease. Abbott's BVS device restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. Abbott's BVS device will be commercialized under the brand name ABSORB.

10 Jan 2011

Enlight Biosciences forms new oral drug delivery technology company

Entrega, Inc., a new company developing oral drug delivery technologies, today announced its formation by Enlight Biosciences, a Boston-based company established in partnership with a group of leading global pharmaceutical companies.

10 Jan 2011

PharPoint Research joins Medidata's ASPire to Win channel partner program

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that PharPoint Research, Inc., a North Carolina-based drug development service company, has joined Medidata's ASPire to Win® channel partner program, bringing the program's partner count to 30 organizations.

10 Jan 2011